High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan
- PMID: 12183246
- PMCID: PMC127412
- DOI: 10.1128/AAC.46.9.2908-2913.2002
High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan
Abstract
Susceptibilities to 16 antimicrobial agents were determined by measurement of MICs for 344 isolates of anaerobic bacteria recovered from patients with significant infections. Resistance rates varied among antimicrobial agents and the species tested. The beta-lactams were more active in gram-positive than in gram-negative anaerobes. Resistance to meropenem was low (<1%). For beta-lactam-beta-lactamase inhibitors, piperacillin-tazobactam was most active for all species (resistance, <6%). The rates of resistance to cefoxitin (31 to 65%) and clindamycin (50 to 70%) for non-Bacteroides fragilis species of the B. fragilis group were higher than those for B. fragilis (4% resistant to cefoxitin and 33% resistant to clindamycin). Among members of B. fragilis group, Bacteroides thetaiotaomicron was the most resistant to clindamycin (70%) and cefoxitin (65%). Rates of susceptibility to imipenem and metronidazole for B. fragilis continue to be high compared to those from a previous study 10 years ago. However, resistance to metronidazole was found recently in five strains of B. fragilis. We analyzed the genetic relationships among the metronidazole-resistant B. fragilis strains by pulsed-field gel electrophoresis. The metronidazole-resistant B. fragilis strains showed genotypic heterogeneity, excluding the dissemination of a single clone.
Figures


Similar articles
-
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.J Antimicrob Chemother. 1993 Mar;31(3):363-72. doi: 10.1093/jac/31.3.363. J Antimicrob Chemother. 1993. PMID: 8486570
-
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649. Antimicrob Agents Chemother. 1993. PMID: 8215278 Free PMC article.
-
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):352-6. doi: 10.1007/BF01962077. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1396757
-
Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.Infection. 1989 May-Jun;17(3):197-200. doi: 10.1007/BF01644030. Infection. 1989. PMID: 2661442 Review.
-
Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S260-9. doi: 10.1093/clinids/6.supplement_1.s260. Rev Infect Dis. 1984. PMID: 6326243 Review.
Cited by
-
Risk of surgical site infection and efficacy of antibiotic prophylaxis: a cohort study of appendectomy patients in Thailand.BMC Infect Dis. 2006 Jul 12;6:111. doi: 10.1186/1471-2334-6-111. BMC Infect Dis. 2006. PMID: 16836755 Free PMC article.
-
Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.Pathog Dis. 2019 Nov 1;77(8):ftz059. doi: 10.1093/femspd/ftz059. Pathog Dis. 2019. PMID: 31603505 Free PMC article.
-
Antimicrobial Resistance in Clostridium and Brachyspira spp. and Other Anaerobes.Microbiol Spectr. 2020 Jan;8(1):10.1128/microbiolspec.arba-0020-2017. doi: 10.1128/microbiolspec.ARBA-0020-2017. Microbiol Spectr. 2020. PMID: 31971162 Free PMC article. Review.
-
Bacteremia caused by Veillonella dispar in an oncological patient.Anaerobe. 2020 Dec;66:102285. doi: 10.1016/j.anaerobe.2020.102285. Epub 2020 Oct 16. Anaerobe. 2020. PMID: 33075505 Free PMC article.
-
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.Antimicrob Agents Chemother. 2008 Sep;52(9):3161-8. doi: 10.1128/AAC.00355-08. Epub 2008 Jul 14. Antimicrob Agents Chemother. 2008. PMID: 18625771 Free PMC article.
References
-
- Aldridge, K. E., D. Ashcraft, K. Cambre, C. L. Pierson, S. G. Jenkins, and J. E. Rosenblatt. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243. - PMC - PubMed
-
- Appleman, M. D., P. N. R. Heseltine, and C. E. Cherubin. 1991. Epidemiology, antimicrobial susceptibility, pathology, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center. Clin. Infect. Dis. 13:12-18. - PubMed
-
- Betriu, C., M. Gomez, M. L. Palau, A. Sanchez, and J. J. Picazo. 1999. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob. Agents Chemother. 43:2320-2322. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases